We conducted a study to determine the prevalence and clinical patterns
of footwear dermatitis, patch testing 50 patients with suspected foot
wear dermatitis and 30 controls with 22 allergens of a shoe series (Ch
emotechnique Diagnostics AB, Malmo, Sweden). The overall prevalence am
ong contact dermatitis cases was 11.7%. The dorsa of the feet and toes
were the commonest sites involved. 70% of patients showed sensitivity
to footwear allergen(s), as opposed to 6.67% of controls. Potassium d
ichromate and colophony were the commonest sensitizers. Other sensitiz
ers were the rubber accelerators 2-mercaptobenzothiazole (MBT) and dip
henylguanidine (DPG) and a dye p-aminoazobenzene. Of the 23 patients p
atch tested with pieces or scrapings of footwear, only 3 showed positi
ve reactions. We recommend that there should be primary and secondary
footwear screening series to detect the responsible allergens, with th
e ultimate objective of providing correct nonallergenic footwear for o
ur patients, with the help of manufacturers and research institutes.